Curetis AG of German obtained a world-wide, non-exclusive license to AcuSept, a biomarker panel, from Acumen Research Laboratories of Singapore. Separately, Acumen signed exclusive, multi-year distribution agreement with Curetis for Unyvero production line, a diagnostics system for severe infectious diseases, in Association of Southeast Asian Nations (ASEAN).The two companies will jointly develop a sepsis host response test based on the AcuSept panel and the Unyvero platform.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
